Literature DB >> 8786121

Structure of the human laminin gamma 2 chain gene (LAMC2): alternative splicing with different tissue distribution of two transcripts.

T Airenne1, H Haakana, K Sainio, T Kallunki, P Kallunki, H Sariola, K Tryggvason.   

Abstract

We have determined the structure of the human laminin gamma 2 chain gene (LAMC2), which is mutated in some patients with junctional epidermolysis bullosa. Eight lambda phage clones isolated from a genomic library and three subgenomic lambda phage clones made from a plasmid artificial chromosome clone spanned 75 kb, including the 55-kb gene. The LAMC2 gene contains 23 exons and is structurally highly homologous with the 28-exon LAMC1 gene (Kallunki et al., 1991, J. Biol. Chem. 266: 221-228), with 16 exons having identical sizes in the two genes. The gene analysis demonstrated that two previously described different size gamma 2 chain cDNAs (Kallunki et al., 1992, J. Cell Biol. 119: 679-693) are the result of alternative splicing. The longer gamma 2 chain is formed by using the coding sequence of the last exon 23, while the shorter gamma 2* chain is formed by using only 22 exons, together with part of the 5' end of intron 22. The two mRNAs were shown to have different expression patterns in 17-week-old human embryonic tissues, with the longer gamma 2 chain transcript strongly expressed in epithelia of all tissues studied, while distinct expression of the shorter gamma 2* chain mRNA was observed only in the cerebral cortex, in lung, and in distal tubules of the kidney.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786121     DOI: 10.1006/geno.1996.0076

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

1.  A mouse model of generalized non-Herlitz junctional epidermolysis bullosa.

Authors:  Jason A Bubier; Thomas J Sproule; Lydia M Alley; Cameron M Webb; Jo-David Fine; Derry C Roopenian; John P Sundberg
Journal:  J Invest Dermatol       Date:  2010-03-25       Impact factor: 8.551

2.  Novel and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: molecular basis and clinical course of Herlitz disease.

Authors:  Christiane Mühle; Qiu-Jie Jiang; Alexandra Charlesworth; Leena Bruckner-Tuderman; Guerrino Meneguzzi; Holm Schneider
Journal:  Hum Genet       Date:  2004-11-05       Impact factor: 4.132

3.  MEGF9: a novel transmembrane protein with a strong and developmentally regulated expression in the nervous system.

Authors:  Ulrike Brandt-Bohne; Douglas R Keene; Fletcher A White; Manuel Koch
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

4.  Involvement of activator protein 1 complexes in the epithelium-specific activation of the laminin gamma2-chain gene promoter by hepatocyte growth factor (scatter factor).

Authors:  J Olsen; O Lefebvre; C Fritsch; J T Troelsen; V Orian-Rousseau; M Kedinger; P Simon-Assmann
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

5.  HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma.

Authors:  S Xiao; M L Lux; R Reeves; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

6.  Laminin isoforms containing the gamma3 chain are unable to bind to integrins due to the absence of the glutamic acid residue conserved in the C-terminal regions of the gamma1 and gamma2 chains.

Authors:  Hiroyuki Ido; Shunsuke Ito; Yukimasa Taniguchi; Maria Hayashi; Ryoko Sato-Nishiuchi; Noriko Sanzen; Yoshitaka Hayashi; Sugiko Futaki; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

7.  Down-regulation of laminin-5 in breast carcinoma cells.

Authors:  K J Martin; C P Kwan; K Nagasaki; X Zhang; M J O'Hare; C M Kaelin; R E Burgeson; A B Pardee; R Sager
Journal:  Mol Med       Date:  1998-09       Impact factor: 6.354

8.  A decreased ratio of laminin-332 beta3 to gamma2 subunit mRNA is associated with poor prognosis in colon cancer.

Authors:  Cherise M Guess; Bonnie J Lafleur; Brandy L Weidow; Vito Quaranta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

Review 9.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

10.  Identification of a novel family of laminin N-terminal alternate splice isoforms: structural and functional characterization.

Authors:  Kevin J Hamill; Lutz Langbein; Jonathan C R Jones; W H Irwin McLean
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.